To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

July 24, 2019___

Today's Rundown

Featured Story

As new prime minister takes the helm, U.K.-based GSK still balks at 'no deal'

It wasn’t the best timing for GlaxoSmithKline’s second-quarter financial call: While CEO Emma Walmsley went through the numbers, Britain’s Prime Minister Theresa May was giving her last speech as PM in Parliament.

Top Stories

GSK drops lung injury drugs as respiratory clear-out continues

GlaxoSmithKline has terminated 11 projects over the past 12 months. The respiratory franchise bore the brunt of the cuts at a time when some GSK staff were questioning the wisdom of investing in the field.

Celgene drops $2.6B Jounce pact, bags rights to macrophage drug

Celgene has restructured its alliance with Jounce, dropping the $2.6 billion pact it formed in 2016 while securing full rights to a single asset. The changes cut Celgene’s ties to programs that overlap with those in Bristol-Myers Squibb’s portfolio.

FDA calls off AdComm for Intra-Cellular's schizophrenia prospect

Intra-Cellular Therapies’ lead asset hit a snag Tuesday afternoon as the FDA canceled an advisory panel meeting scheduled for next Wednesday. The company is developing lumateperone as an oral med for schizophrenia.

TScan Therapeutics uncloaks with $48M to unleash new TCR targets

TScan Therapeutics launched Wednesday with $48 million, a star-studded management team and T-cell receptor technology out of Harvard University. The company aims to uncover new targets for T-cell therapies.

IBM Watson Health's new manager talks about returning to basics, doubling down

Former Ciox Health CEO Paul Roma has been installed as the new general manager of IBM's Watson Health unit with plans to refocus the project’s efforts on where it's seen success.

Resources

[Whitepaper] The Truth about Physician Referrals and Clinical Trials

The Study Voices survey challenges the myth that physicians won’t refer patients to clinical trials, and it identifies opportunities to engage physicians as partners in the enrollment process.

[eBook] Small molecules 2.0: the bigger picture

The highest number of NCEs approved by the FDA…the fastest growing small molecule clinical pipeline reported in 20 years…these are exciting times for our industry.

[Paid Marketplace] Faster Research. Smarter Bibliographies.

Cut your research time in half - with an easy-to-use app for scientists that combines full-featured reference management with integrated search and on-demand document delivery.

[Video] Almac Launches Almac Adapt™ - a New Patient-Centric Supply Solution

Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials

[Video] PwC Webcast: Goodbye cost shifting, hello employer activism

How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce?

[Whitepaper] Transforming the future of medical shipments

The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets.

[Whitepaper] IoT Technologies & Informatics Integration in Pharmaceuticals

Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies.

[Whitepaper] Managing Demand Uncertainty in Biologics Production

When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here.

[Report] NEW Report on 2019 e-Prescribing Regulations and Potential Impact

Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies.

[Whitepaper] Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation

Anticipate challenges in formulation early.

[Whitepaper] Managing Comorbidities in Type 2 Diabetes – Real World Evidence for Change

Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events